These improvements correlated with the degree of weight loss, further strengthening the cardiovascular case embedded in retatrutide results
It also drives cravings for high-sugar, high-fat foods by stimulating the same reward pathways that GLP-1 medications work to quiet
^When incorporated into a weight management plan that includes diet and exercise
Phase 2 Trial Results: Weight Loss Outcomes in Type 2 Diabetes At the highest 12 mg dose, adults with type 2 diabetes achieved approximately 16.9% mean body weight reduction from baseline at 24 weeks in a randomised, placebo-controlled phase 2 trial published in The Lancet (2023)
Some studies suggest these medications can improve mood, while others warn of risks
Animal studies have also shown that portal vein GLP-1 weakens intestinal fat absorption and chylomicron production through the vagal enteric-brain-liver axis, and reduces postprandish and fasting blood lipids [79]